SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $33,462 | -80.3% | 25,740 | +13.4% | 0.00% | -83.3% |
Q4 2021 | $170,000 | -16.7% | 22,696 | 0.0% | 0.01% | -14.3% |
Q3 2021 | $204,000 | -16.0% | 22,696 | +11.8% | 0.01% | -22.2% |
Q2 2021 | $243,000 | -4.3% | 20,298 | 0.0% | 0.01% | -10.0% |
Q1 2021 | $254,000 | -24.4% | 20,298 | -5.6% | 0.01% | -28.6% |
Q4 2020 | $336,000 | +73.2% | 21,513 | +4.9% | 0.01% | +55.6% |
Q3 2020 | $194,000 | +5.4% | 20,505 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $184,000 | -31.6% | 20,505 | +16.2% | 0.01% | -59.1% |
Q2 2014 | $269,000 | – | 17,644 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |